P8A:SGX
Cordlife Group Ltd
SGD 0,12
0,00%
(0,00) 1 HR
12 Okt, 09.49.20 GMT+8 · SGD
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk P8A...
Kapitalisasi pasar
32,37 jt
Volume rata-rata
1,32 rb
Volume
0,00
Harga tinggi dalam 52 minggu terakhir
SGD 0,26
Harga rendah dalam 52 minggu terakhir
SGD 0,10
EPS
-SGD 0,04
Saham beredar
267,53 jt
Jumlah karyawan
111
Kapitalisasi pasar
32,37 jt
Volume rata-rata
1,32 rb
Volume
0,00
Harga tinggi dalam 52 minggu terakhir
SGD 0,26
Harga rendah dalam 52 minggu terakhir
SGD 0,10
EPS
-SGD 0,04
Saham beredar
267,53 jt
Jumlah karyawan
111
Artikel berita
Dari sumber web dan partner berita
Investing.com Indonesia
·
9 jam yang lalu
Mengapa SPDR S&P 500 ETF Trust turun hari ini?
XTB.com
·
1 hari yang lalu
Dow Jones Naik 1%, Yield Treasury AS Turun ke 5,1%
XTB.com
·
13 jam yang lalu
Dow Jones Naik, Nasdaq dan Saham AI Turun
Profil
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn.
In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
Tentang Cordlife Group Ltd
CEOYiu Pang Fai
Karyawan111
Didirikan2 Mei 2001
Kantor Pusat-
SektorHealth care provider
Situscordlife.com